Publication | Open Access

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

OncologyImmune Checkpoint InhibitorConsolidation NivolumabCancer TreatmentIpilimumab Versus ObservationMedicineRadiation OncologyLung CancerChemo-radiotherapy – Results